Proteome Sciences (LON:PRM) Stock Falls 1.4% – Time to Sell?

Proteome Sciences plc (LON:PRM – Get Free Report) shares traded down 1.4% during trading on Tuesday. The stock traded as low as GBX 1.04 and last traded at GBX 1.38. Approximately 499,557 shares changed hands during mid-day trading, an increase of 45% from the average daily volume of 345,071 shares. The stock had previously closed at GBX 1.40.

Proteome Sciences Stock Performance

The stock’s 50 day moving average is GBX 1.43 and its two-hundred day moving average is GBX 1.61. The stock has a market capitalization of £3.68 million, a price-to-earnings ratio of -1.46 and a beta of 0.16. The company has a current ratio of 0.12, a quick ratio of 0.37 and a debt-to-equity ratio of -161.07.

Proteome Sciences (LON:PRM – Get Free Report) last posted its quarterly earnings data on Wednesday, September 16th. The company reported GBX (0.41) earnings per share for the quarter. Proteome Sciences had a positive return on equity of 23.85% and a negative net margin of 61.46%.

About Proteome Sciences

(Get Free Report)

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.

Recommended Stories

Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.